• Profile
Close

Liposomal bupivacaine efficacy for post-operative pain following posterior vaginal surgery: A randomized, double-blind, placebo controlled trial

American Journal of Obstetrics and Gynecology Oct 05, 2018

Jones CL, et al. - In this randomized, double-blinded, placebo-controlled trial including 100 participants who were recruited from the Walter Reed National Military Medical Center urogynecology clinic, researchers compared study medication (extended-release liposomal bupivacaine) to placebo (saline) regarding the cumulative post-operative vaginal pain on days 1 and 3 following posterior vaginal wall surgery. In addition, they evaluated vaginal pain on post-operative day 7 and total morphine-equivalent narcotic usage on days 1, 3, and 7. Findings revealed no significant decrease in post-operative pain or decrease in narcotic medication usage with the use of extended-release liposomal bupivacaine in posterior vaginal wall surgeries vs saline.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay